4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-058328
Chief Medical Officer sold 2,666 shares at an average $10.66 ($28,413)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2023-12-11 | Sale 10b5-1 | −1,688 | $10.72 | $18,095 | 170,074 | D |
| Farwell Wildon Chief Medical Officer | 2023-12-12 | Sale 10b5-1 | −978 | $10.55 | $10,318 | 169,096 | D |
| Open-market sales · 2,666 sh · avg $10.66 · $28,413 | |||||||
Loading xslF345X05/doc4.xml…